Home › Funds › Integral Health Asset Management, LLC › NBIX

Integral Health Asset Management, LLC position in NBIX

NEUROCRINE BIOSCIENCES INC · Health Care

Integral Health Asset Management, LLC reported holding 150,000 shares of NBIX (NEUROCRINE BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$21.3M, representing 1.38% of its reported portfolio and ranking #17 among its reported holdings. Integral Health Asset Management, LLC has disclosed NBIX holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)150.00K sh
Reported value held$21.28M
Portfolio Weight1.38%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Integral Health Asset Management, LLC's NBIX position evolved

Integral Health Asset Management, LLC first disclosed a stake in NBIX in Q3 2023 at 85,000 shares (US$9.6M). The position peaked in Q2 2026 at 150,000 shares, worth US$25.3M. Across 12 filings, Integral Health Asset Management, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 150,000 shares valued at US$21.3M. Notable position changes include a 67% increase in Q1 2024 (shares were roughly flat over the following quarter), a 53% trim in Q2 2024 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 85.00K $9.56M New
Q4 2023 90.00K $11.86M Add
Q1 2024 150.00K $20.69M Add
Q2 2024 70.00K $9.64M Reduce
Q4 2024 160.00K $21.84M New
Q1 2025 150.00K $16.59M Reduce
Q2 2025 150.00K $18.85M Hold
Q3 2025 150.00K $21.06M Hold
Q4 2025 150.00K $21.27M Hold
Q1 2026 150.00K $19.76M Hold
Q2 2026 150.00K $25.28M Hold
Q3 2026 150.00K $21.28M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NBIX and 13F data

NBIX (NEUROCRINE BIOSCIENCES INC) is a Health Care company. 29 other funds we track also report a position in NBIX — the largest reported positions include Renaissance Technologies (US$326.3M), Vestal Point Capital, LP (US$316.8M), RTW INVESTMENTS, LP (US$133.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NBIX

All NBIX fund holders →

FAQ

How long has Integral Health Asset Management, LLC held NBIX?

Integral Health Asset Management, LLC has disclosed NBIX holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Integral Health Asset Management, LLC's current position in NBIX?

As of Q3 2026, Integral Health Asset Management, LLC holds 150.00K shares of NBIX (NEUROCRINE BIOSCIENCES INC), valued at $21.28M, representing 1.38% of its reported portfolio and ranking #17.

Has Integral Health Asset Management, LLC been buying or selling NBIX?

In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC held unchanged its position in NBIX. The position peaked in Q2 2026 at 150.00K shares.

Which other funds hold NBIX?

Other major institutional holders of NBIX include Renaissance Technologies, Vestal Point Capital, LP, RTW INVESTMENTS, LP, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.